MoneyWorks4Me

Earum Pharmaceuticals informs about disclosure

27 Apr 2022 Evaluate

Earum Pharmaceuticals has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Payal B Patel.

The above information is a part of company’s filings submitted to BSE.

Peers